433 related articles for article (PubMed ID: 27825512)
1. The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease.
Belkouch M; Hachem M; Elgot A; Lo Van A; Picq M; Guichardant M; Lagarde M; Bernoud-Hubac N
J Nutr Biochem; 2016 Dec; 38():1-11. PubMed ID: 27825512
[TBL] [Abstract][Full Text] [Related]
2. Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: Can we reconcile the evidence?
Cunnane SC; Chouinard-Watkins R; Castellano CA; Barberger-Gateau P
Prostaglandins Leukot Essent Fatty Acids; 2013 Jan; 88(1):61-70. PubMed ID: 22575581
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Docosahexaenoic Acid on Alzheimer's Disease: Is There a Role of the Blood-Brain Barrier?
Pan Y; Khalil H; Nicolazzo JA
Curr Clin Pharmacol; 2015; 10(3):222-41. PubMed ID: 26338174
[TBL] [Abstract][Full Text] [Related]
4. Carriers of an apolipoprotein E epsilon 4 allele are more vulnerable to a dietary deficiency in omega-3 fatty acids and cognitive decline.
Nock TG; Chouinard-Watkins R; Plourde M
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Oct; 1862(10 Pt A):1068-1078. PubMed ID: 28733268
[TBL] [Abstract][Full Text] [Related]
5. ω-3 fatty acids in the prevention of cognitive decline in humans.
Cederholm T; Salem N; Palmblad J
Adv Nutr; 2013 Nov; 4(6):672-6. PubMed ID: 24228198
[TBL] [Abstract][Full Text] [Related]
6. No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer's Disease: A Randomised Controlled Trial.
Phillips MA; Childs CE; Calder PC; Rogers PJ
Int J Mol Sci; 2015 Oct; 16(10):24600-13. PubMed ID: 26501267
[TBL] [Abstract][Full Text] [Related]
7. DHA Selectively Protects SAMP-8-Associated Cognitive Deficits Through Inhibition of JNK.
Vela S; Sainz N; Moreno-Aliaga MJ; Solas M; Ramirez MJ
Mol Neurobiol; 2019 Mar; 56(3):1618-1627. PubMed ID: 29911253
[TBL] [Abstract][Full Text] [Related]
8. Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer's disease.
Patrick RP
FASEB J; 2019 Feb; 33(2):1554-1564. PubMed ID: 30289748
[TBL] [Abstract][Full Text] [Related]
9. Why Have the Benefits of DHA Not Been Borne Out in the Treatment and Prevention of Alzheimer's Disease? A Narrative Review Focused on DHA Metabolism and Adipose Tissue.
Heath RJ; Wood TR
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769257
[TBL] [Abstract][Full Text] [Related]
10. Low Phytanic Acid-Concentrated DHA Prevents Cognitive Deficit and Regulates Alzheimer Disease Mediators in an ApoE
Ruiz-Roso MB; Echeverry-Alzate V; Ruiz-Roso B; Quintela JC; Ballesteros S; Lahera V; de Las Heras N; López-Moreno JA; Martín-Fernández B
Nutrients; 2018 Dec; 11(1):. PubMed ID: 30577526
[TBL] [Abstract][Full Text] [Related]
11. Towards a nutritional approach for prevention of Alzheimer's disease: biochemical and cellular aspects.
Florent-Béchard S; Malaplate-Armand C; Koziel V; Kriem B; Olivier JL; Pillot T; Oster T
J Neurol Sci; 2007 Nov; 262(1-2):27-36. PubMed ID: 17681547
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review.
Canhada S; Castro K; Perry IS; Luft VC
Nutr Neurosci; 2018 Oct; 21(8):529-538. PubMed ID: 28466678
[TBL] [Abstract][Full Text] [Related]
13. Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2.
Vandal M; Alata W; Tremblay C; Rioux-Perreault C; Salem N; Calon F; Plourde M
J Neurochem; 2014 May; 129(3):516-26. PubMed ID: 24345162
[TBL] [Abstract][Full Text] [Related]
14. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease.
Hashimoto M; Hossain S
J Pharmacol Sci; 2011; 116(2):150-62. PubMed ID: 21606627
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance.
Su HM
J Nutr Biochem; 2010 May; 21(5):364-73. PubMed ID: 20233652
[TBL] [Abstract][Full Text] [Related]
17. Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline.
Yurko-Mauro K
Curr Alzheimer Res; 2010 May; 7(3):190-6. PubMed ID: 20088810
[TBL] [Abstract][Full Text] [Related]
18. Fish, docosahexaenoic acid and Alzheimer's disease.
Cunnane SC; Plourde M; Pifferi F; Bégin M; Féart C; Barberger-Gateau P
Prog Lipid Res; 2009 Sep; 48(5):239-56. PubMed ID: 19362576
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid facts, Part IV: docosahexaenoic acid and Alzheimer's disease. A story of mice, men and fish.
Pauwels EK; Volterrani D; Mariani G; Kairemo K
Drug News Perspect; 2009 May; 22(4):205-13. PubMed ID: 19536365
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
